Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Victoza
| Field | Information |
|---|---|
| Medication Name | Victoza |
| Generic Name | Liraglutide |
| Boxed/Label Warning | Possible risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Avoid use in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). |
| Purpose | To improve blood sugar control in adults and children (10 years and older) with type 2 diabetes mellitus, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. |
| Mechanism of Action | Glucagon-like peptide-1 (GLP-1) receptor agonist; increases insulin release when glucose levels are high, decreases glucagon secretion, and slows gastric emptying. |
| Dosage Forms | Injectable solution (pre-filled pen) |
| Available Strengths | 6 mg/mL (delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg per injection) |
| Dosage Frequency | Once daily |
| Common Side Effects | Nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, headache |
| Serious Side Effects | Pancreatitis, gallbladder disease, kidney problems, severe allergic reactions, hypoglycemia (low blood sugar), thyroid tumors (rare) |
| Drug Interactions | Insulin and other diabetes medications (sulfonylureas, glinides), warfarin, drugs that affect gastric emptying. |
| Important Notes | Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites. Monitor blood glucose levels regularly. Not for use in type 1 diabetes or diabetic ketoacidosis. |
| Storage | Store unused pens in the refrigerator. Do not freeze. After first use, pens can be stored at room temperature for up to 30 days. |
| Missed Dose | Take the missed dose as soon as you remember, but do not double the dose on the same day. |
| Alternatives | Ozempic (semaglutide), Trulicity (dulaglutide), Bydureon (exenatide), Januvia (sitagliptin) |
Victoza Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Ozempic (semaglutide) | GLP-1 receptor agonist | Administered once weekly. Also available in oral form (Rybelsus). |
| Trulicity (dulaglutide) | GLP-1 receptor agonist | Administered once weekly. |
| Bydureon (exenatide) | GLP-1 receptor agonist | Administered once weekly. |
| Januvia (sitagliptin) | DPP-4 inhibitor | Oral medication; enhances the effects of GLP-1. |
Victoza Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Pancreatitis (severe abdominal pain, vomiting) |
| Diarrhea | Gallbladder disease (right upper abdominal pain) |
| Vomiting | Kidney problems (decreased urination, swelling) |
| Constipation | Severe allergic reactions (rash, itching, swelling, difficulty breathing) |
| Abdominal pain | Hypoglycemia (low blood sugar, especially when used with other diabetes medications) |
| Decreased appetite | Thyroid tumors (rare) |
| Headache | Increased heart rate |
Victoza Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes Mellitus | 0.6 mg once daily | 1.2 mg or 1.8 mg once daily (titrated as needed and tolerated) | Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites. |
Victoza Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $60 |
| Without Insurance (U.S.) | $1440 |
| From Canada | $256.99 |
